Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial
Abstract
Ribavirin aerosol therapy can be safely administered to mechanically ventilated children with severe respiratory syncytial virus lower respiratory tract disease. However, this therapy does not appear to affect immediate clinical outcome in such patients.
Keywords
respiration
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
Infant
Prospective Studies
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Artificial
intensive care units
aerosols
respiratory syncytial virus infections / drug therapy*
pmid:8143465
doi:10.1097/00003246-199404000-00010
k l meert
a p sarnaik
m w lieh-lai
pediatric
respiratory syncytial virus infections / physiopathology
ribavirin / administration & dosage*
Access
Citation
ID:
112585
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112585
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet